NCT05061576 Instructed Home-based Physical Exercise for Patients With Liver Cirrhosis
| NCT ID | NCT05061576 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karolinska University Hospital |
| Condition | Liver Cirrhosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-08-16 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2022-08-16 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will compare two forms of advice regarding physical activity for patients hospitalized with cirrhosis that are preparing for leaving the hospital. One arm consists of current standard of care: simple oral advice on exercise. One arm instead gives patients a structured but simple paper template on physical activity.
Eligibility Criteria
Inclusion Criteria: * Liver cirrhosis diagnosed with previous clinical assessment and radiology (de-formed liver, noduli, varices, collaterals, splenomegaly \>12 cm) or with biopsy (fibrosis grade 4). ICD-code K70.3, K74.6. * MELD \< 25 * Understanding the Swedish language. * Signed informed consent. Exclusion Criteria: * Performance status ≥3. * Severe pain which prevents the patient to perform the physical activities, as judged by the attending physician at time of discharge. * Previously liver transplanted * Unlikely to be compliant to follow-up (living in other parts of Sweden), as judged by the attending physician at time of discharge.
Contact & Investigator
Hannes Hagström, MD PhD
PRINCIPAL INVESTIGATOR
Karolinska University Hospital
Frequently Asked Questions
Who can join the NCT05061576 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Liver Cirrhosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05061576 currently recruiting?
Yes, NCT05061576 is actively recruiting participants. Contact the research team at hannes.hagstrom@ki.se for enrollment information.
Where is the NCT05061576 trial being conducted?
This trial is being conducted at Stockholm, Sweden.
Who is sponsoring the NCT05061576 clinical trial?
NCT05061576 is sponsored by Karolinska University Hospital. The principal investigator is Hannes Hagström, MD PhD at Karolinska University Hospital. The trial plans to enroll 100 participants.